Aquila Bioscience, an Irish company based at NUI Galway, and the Irish Defence Forces have announced a collaboration to provide soldiers with its groundbreaking Anti-Bioagent Wipe (ABwipeTM).

Four-year collaboration

Aquila Bioscience and the Irish Defence Forces have been collaborating on this technology for more than four years, with the Ordnance Corps actively engaged in the concept and product trials.

Working with the Irish Defence Forces, the Department of Defence and the European Defence Agency Aquila Bioscience has developed a novel, safe, effective and environmentally friendly technology to decontaminate surfaces from bacterial, viral and biotoxin threats.

ABwipeTM technology serves as a decontamination wipe for first-responders, healthcare workers and for civilians to significantly reduce and prevent pathogen transmission from person-to-person and therefore reducing the spread, panic and impact of the pathogen, as is the case with coronavirus COVID-19.

Aquila Bioscience’s ABwipeTM contains components that bind to and decontaminate the surface, taking advantage of the virus’s own attack mechanism (in this case, carbohydrates and proteins).

No harmful ingredients

Because ABwipeTM contains no harmful ingredients, it can also be used on skin and sensitive mucosal areas such as eyes, nose and mouth (main portal for virus infection). Most existing decontamination solutions contain chemicals that are harmful to the skin, health of the user and to the environment.

ABwipeTM technology was developed to safely and effectively decontaminate multiple bio-threat agents (including viruses), and its use will significantly reduce the spread of COVID19 and will help ensure that first responders and emergency workers are kept safe to allow them to react when called upon.

Professor Lokesh Joshi, co-founder and director of Aquila Bioscience, and vice-president for research and innovation at NUI Galway said: “The concept for this technology was driven by the Irish Defence Forces and an identified capability need in the Chemical, Biological, Radiological & Nuclear (CBRN) protection measures.

European Defence Agency supported research

"The innovative concept resulted in European Defence Agency supported research and development by Aquila Bioscience at NUI Galway and is just now ready for mass manufacture and could be a valuable technology in the fight against the coronavirus.

"This unprecedented situation requires unprecedented measures and the Defence Forces have committed to the purchase of a consignment of the AB wipes for troop force protection measures.”

At this time of global urgency and unknown impact on human lives and economy because of the COVID- 19 pandemic, ABwipeTM will serve as an essential tool in the arsenal against coronavirus to stem its spread and to save lives.

For more details see www.aquilabioscience.com or contact info@aquilabioscience.com